R&D Projects

TRADION P

Expert system for personalized diagnosis and treatment of cancer patients

The main objective of this project is the development of an expert system for the diagnosis and personalised treatment of cancer patients that allows the disease to be modelled, selecting, planning, and applying a personalised treatment for each patient. This thereby facilitates the dynamic evaluation of the therapy, the optimisation of results, and improvement in the quality of care, as well as the use of health system resources. The aim is to develop a series of diagnostic tests to enable the integrated and individualised analysis of each case.

In this prototype, a complex multimodal database correlates the patient’s clinical history with histological imaging data, multiple immunofluorescence results, point mutations in genes of interest, alterations in DNA methylation and copy number variations of specific genes via FISH (Fluorescent In Situ Hybridisation).

5

foundations are collaborating in the project

detailGrey

A complex database correlates the patient’s medical records with health system data and resources.

In order to successfully achieve the project’s aims, a consortium has been formed with INDRA and LORGEN. In addition, Atrys Health collaborates with the San Cecilio University Hospital, the Virgen de las Nieves University Hospital, the Andalusian Tumour Bank Network, the Granada-EASP Cancer Registry, the GENYO research centre in Granada, and the Príncipe Felipe Research Centre in Valencia.

To achieve the objectives

2010-2013

The project is partially co-funded by the Centre for the Development of Industrial Technology (CDTI) and the European Regional Development Fund (ERDF).

Financial blockers

Related projects

ZITOMAB

ZITOMAB

Second-generation antitumor immunotherapies: antibodies and toxin-conjugated nanobodies using Inteins-ZIP

Read more
TRADION P

TRADION P

Expert system for personalized diagnosis and treatment of cancer patients

Read more
RAP-ID19

RAP-ID19

Diagnostic device for rapid detection of COVID-19

Read more
SURVEPROST

SURVEPROST

Molecular signature in liquid biopsy for active surveillance in prostate cancer

Read more